Patients who fail to pop pills on time could soon benefit from having a chip on their shoulder, under a ground-breaking electronic system being developed by Novartis, the Swiss pharmaceuticals group.
The company is testing technology that inserts a tiny microchip into each pill swallowed and sends a reminder by text message if they fail to follow their doctors' prescriptions.
The partnership with Proteus Biomedical, which originally developed the technology, is one of several alliances under development by Novartis as it and rival pharmaceuticals companies attempt to maintain high prices for innovative medicines by ensuring that they are taken as the doctor ordered.
您已閱讀35%（672字），剩餘65%（1254字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。